Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H (2009) Hypertrophic scars and keloids–a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg.;35(2):171– 81. https://doi.org/10.1111/j.1524-4725.2008.34406.x. PMID: 19215252

Roohaninasab M, Khodadad F, Sadeghzadeh-Bazargan A, Atefi N, Zare S, Jafarzadeh A, Rahimi ST, Nouri M, Nilforoushzadeh MA, Behrangi E, Goodarzi A (2023) Efficacy of fractional CO2 laser in combination with stromal vascular fraction (SVF) compared with fractional CO2 laser alone in the treatment of burn scars: a randomized controlled clinical trial. Stem Cell Res Ther 14(1):269. https://doi.org/10.1186/s13287-023-03480-8PMID: 37742019; PMCID: PMC10518108

Article  PubMed  PubMed Central  CAS  Google Scholar 

Slemp AE, Kirschner RE (2006) Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr.;18(4):396–402. https://doi.org/10.1097/01.mop.0000236389.41462.ef. PMID: 16914994

Jafarzadeh A, PourMohammad A, Goodarzi A (2024) A systematic review of the efficacy, safety and satisfaction of regenerative medicine treatments, including platelet-rich plasma, stromal vascular fraction and stem cell-conditioned medium for hypertrophic scars and keloids. Int Wound J 21(4):e14557. https://doi.org/10.1111/iwj.14557Epub 2023 Dec 21. PMID: 38126221; PMCID: PMC10961894

Article  PubMed  Google Scholar 

Alster T, Zaulyanov L (2007) Laser scar revision: a review. Dermatol Surg 33(2):131–140. https://doi.org/10.1111/j.1524-4725.2006.33030.x. Erratum in: Dermatol Surg. 2007;33(6):770. Zaulyanov-Scanlon, Larissa [corrected to Zaulyanov, Larissa]. PMID: 17300597

Kivi MK, Jafarzadeh A, Hosseini-Baharanchi FS, Salehi S, Goodarzi A (2024) The efficacy, satisfaction, and safety of carbon dioxide (CO2) fractional laser in combination with pulsed dye laser (PDL) versus each one alone in the treatment of hypertrophic burn scars: a single-blinded randomized controlled trial. Lasers Med Sci.;39(1):69. https://doi.org/10.1007/s10103-024-03976-6. PMID: 38376542

Oliveira GV, Chinkes D, Mitchell C, Oliveras G, Hawkins HK, Herndon DN (2005) Objective assessment of burn scar vascularity, erythema, pliability, thickness, and planimetry. Dermatol Surg.;31(1):48–58. https://doi.org/10.1111/j.1524-4725.2005.31004. PMID: 15720096

Zhibo X, Miaobo Z (2008) Botulinum toxin type a affects cell cycle distribution of fibroblasts derived from hypertrophic scar. J Plast Reconstr Aesthet Surg 61(9):1128–1129. https://doi.org/10.1016/j.bjps.2008.05.003Epub 2008 Jun 13. PMID: 18555763

Article  PubMed  Google Scholar 

Bazargan AS, Tabavar A, Roohaninasab M, Ali ZN, Tavana Z, Montazeri SSM, Jafarzadeh A (2023) Evaluation of the effect of botulinum toxin injection in aggravating or improving seborrheic dermatitis symptoms: a prospective, single-arm clinical trial. Skin Res Technol 29(10):e13478. https://doi.org/10.1111/srt.13478PMID: 37881062; PMCID: PMC10517391

Article  PubMed  PubMed Central  Google Scholar 

Gauglitz GG (2013) Management of keloids and hypertrophic scars: current and emerging options. Clin Cosmet Investig Dermatol.;6:103– 14. doi: 10.2147/CCID.S35252. PMID: 23637546; PMCID: PMC3639020

Asilian A, Darougheh A, Shariati F (2006) New combination of triamcinolone, 5-Fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg.;32(7):907– 15. https://doi.org/10.1111/j.1524-4725.2006.32195.x. PMID: 16875473

Kiil J (1977) Keloids treated with topical injections of triamcinolone acetonide (kenalog). Immediate and long-term results. Scand J Plast Reconstr Surg.;11(2):169– 72. https://doi.org/10.3109/02844317709025514. PMID: 345427

Wong TS, Li JZ, Chen S, Chan JY, Gao W (2016) The efficacy of Triamcinolone Acetonide in Keloid Treatment: a systematic review and Meta-analysis. Front Med (Lausanne) 3:71. https://doi.org/10.3389/fmed.2016.00071PMID: 28083534; PMCID: PMC5186775

Article  PubMed  Google Scholar 

Sohrabi C, Goutos I (2020) The use of botulinum toxin in keloid scar management: a literature review. Scars Burn Heal 6:2059513120926628. https://doi.org/10.1177/2059513120926628PMID: 32637157; PMCID: PMC7323272

Article  PubMed  PubMed Central  Google Scholar 

Knowles A, Glass DA 2 (2023) nd. Keloids and Hypertrophic Scars. Dermatol Clin.;41(3):509–517. https://doi.org/10.1016/j.det.2023.02.010. Epub 2023 Apr 4. PMID: 37236718

Kim EY, Hussain A, Khachemoune A (2023) Evidence-based management of keloids and hypertrophic scars in dermatology. Arch Dermatol Res.;315(6):1487–1495. https://doi.org/10.1007/s00403-022-02509-x. Epub 2022 Dec 11. PMID: 36504113

Huang Y, Peng T, Hu W, Gao X, Chen Y, Zhang Q, Wu C, Pan X (2022) Fully armed photodynamic therapy with spear and shear for topical deep hypertrophic scar treatment. J Control Release 343:408–419 Epub 2022 Jan 30. PMID: 35104572

Article  PubMed  CAS  Google Scholar 

Finnerty CC, Jeschke MG, Branski LK, Barret JP, Dziewulski P, Herndon DN (2016) Hypertrophic scarring: the greatest unmet challenge after burn injury. Lancet 388(10052):1427–1436. https://doi.org/10.1016/S0140-6736(16)31406-4PMID: 27707499; PMCID: PMC5380137

Article  PubMed  PubMed Central  Google Scholar 

Shu F, Liu H, Lou X, Zhou Z, Zhao Z, Liu Y, Bai X, Luo P, Zheng Y, Xiao S, Xia Z (2022) Analysis of the predictors of hypertrophic scarring pain and neuropathic pain after burn. Burns 48(6):1425–1434 Epub 2021 Aug 15. PMID: 34670714

Article  PubMed  Google Scholar 

Rimmer SN, Chandy RJ, Khan D, Feldman SR (2023) Recurrence rates in the treatment of keloids and hypertrophic scars with intralesional triamcinolone combined with other intralesional agents. Arch Dermatol Res.;315(10):2757–2767. https://doi.org/10.1007/s00403-023-02662-x. Epub 2023 Jul 11. PMID: 37432467

Liang Y, Ding A, Lv D, Wang D, Zhou R (2023) Comparison of Ultrasound-assisted low-dose Versus Medium-Dose 5-Fluorouracil and Triamcinolone Acetonide in the treatment of hypertrophic scar. Dermatol Ther 2023. https://doi.org/10.1155/2023/5245805

Walsh LA, Wu E, Pontes D, Kwan KR, Poondru S, Miller CH, Kundu RV (2023) Keloid treatments: an evidence-based systematic review of recent advances. Syst Rev 12(1):42. https://doi.org/10.1186/s13643-023-02192-7PMID: 36918908; PMCID: PMC10012475

Article  PubMed  PubMed Central  Google Scholar 

Bailey JK, Burkes SA, Visscher MO, Whitestone J, Kagan RJ, Yakuboff KP, Warner P, Randall Wickett R (2012) Multimodal quantitative analysis of early pulsed-dye laser treatment of scars at a pediatric burn hospital. Dermatol Surg.;38(9):1490-6. https://doi.org/10.1111/j.1524-4725.2012.02451.x. Epub 2012 Jun 5. PMID: 22672578

Chan HH, Wong DS, Ho WS, Lam LK, Wei W (2004) The use of pulsed dye laser for the prevention and treatment of hypertrophic scars in chinese persons. Dermatol Surg.;30(7):987– 94; discussion 994. https://doi.org/10.1111/j.1524-4725.2004.30303.x. PMID: 15209788

Rahman SHA, Mohamed MS, Hamed AM (2021) Efficacy and safety of nd:YAG laser alone compared with combined nd:YAG laser with intralesional steroid or botulinum toxin A in the treatment of hypertrophic scars. Lasers Med Sci 36(4):837–842. https://doi.org/10.1007/s10103-020-03120-0Epub 2020 Aug 18. PMID: 32812129

Article  PubMed  Google Scholar 

Al-Mohamady A-S, Ibrahim SM, Muhammad MM (2016) Pulsed dye laser versus long-pulsed nd:YAG laser in the treatment of hypertrophic scars and keloid: a comparative randomized split-scar trial. J Cosmet Laser Ther 18(4):208–212 Epub 2016 Mar 8. PMID: 26735516

Article  PubMed  Google Scholar 

Ziade M, Domergue S, Batifol D, Jreige R, Sebbane M, Goudot P, Yachouh J (2013) Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study. J Plast Reconstr Aesthet Surg 66(2):209–214 Epub 2012 Oct 25. PMID: 23102873

Article  PubMed  Google Scholar 

Shin J, Cho JT, Park SI, Jung SN (2019) Combination therapy using non-ablative fractional laser and intralesional triamcinolone injection for hypertrophic scars and keloids treatment. Int Wound J 16(6):1450–1456. https://doi.org/10.1111/iwj.13213Epub 2019 Sep 2. PMID: 31475470; PMCID: PMC7948603

Article  PubMed  PubMed Central  Google Scholar 

Elhefnawy AM Assessment of intralesional injection of botulinum toxin type A injection for hypertrophic scars. Indian J Dermatol Venereol Leprol. 2016 May-Jun;82(3):279– 83. https://doi.org/10.4103/0378-6323.173586. PMID: 27088929

Worley B, Kim K, Jain-Poster K, Reynolds KA, Merkel EA, Kang BY, Dirr MA, Anvery N, Christensen RE, Hisham FI, Ibrahim SA, Asadbeigi SN, Poon E, Alam M (2023) Treatment of traumatic hypertrophic scars and keloids: a systematic review of randomized control trials. Arch Dermatol Res 315(7):1887–1896. https://doi.org/10.1007/s00403-023-02535-3Epub 2023 Feb 13. PMID: 36781457

Article  PubMed  Google Scholar 

Dilmaghani S, Behrangi E, Mazandarani M, Pourali A, Sadeghi S, Khosravi M, Goodarzi A (2022) Needling, lasers, and Meso-Botox for hypertrophic and keloidal scars: a comprehensive review study on promising procedural treatments. J Family Med Prim Care 11(8):4195–4204. https://doi.org/10.4103/jfmpc.jfmpc_1657_21Epub 2022 Aug 30. PMID: 36352978; PMCID: PMC9638564

Article  PubMed  PubMed Central  Google Scholar